GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jeisys Medical Inc (XKRX:287410) » Definitions » Capital Expenditure

Jeisys Medical (XKRX:287410) Capital Expenditure : ₩-20,138.78 Mil (TTM As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Jeisys Medical Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Jeisys Medical's cash flow for capital expenditures for the three months ended in Jun. 2024 was ₩-6,503 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jun. 2024 was ₩-20,138.78 Mil.


Jeisys Medical Capital Expenditure Historical Data

The historical data trend for Jeisys Medical's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jeisys Medical Capital Expenditure Chart

Jeisys Medical Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial - -2,977.25 -2,783.61 -13,511.89 -15,017.61

Jeisys Medical Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,162.43 -428.27 -12,818.95 -388.99 -6,502.58

Jeisys Medical Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-20,138.78 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jeisys Medical Business Description

Traded in Other Exchanges
N/A
Address
76 Eulji-ro, Jung-gu, Seoul, KOR, 04538
Jeisys Medical Inc is a medical device manufacturer that produces high-end products for plastic surgeons, dermatologists, physicians, and healthcare professionals. Some of its products include ULTRAcel Q+ system, Cellec V system, LIPOcel, AcGen, TRI-BEAM Premium, Edge ONE, and SmoothCool.

Jeisys Medical Headlines

No Headlines